Companies

Search, filter and compare every US company we cover.

Search companies

Sector

Industry

Size

Today

Profitable Growing

Add filter

Clear all

Net debt

Min billion $ Max billion $

209 companies match

Company	Industry	Market cap	Price	Day change	Revenue	Revenue growth	Operating margin	P/E	5-yr growth	Gross margin	Net margin	Free cash flow	FCF margin	Return on capital	Return on equity	Net debt	Net debt / EBITDA	Dividends + buybacks	Share count change	F-score	Insider buys (90d)	Insider sales (90d)
BeOne Medicines Ltd.ONC	Pharmaceutical Preparations	$568.5B	$377.63	1.2%	$5.3B	40.2%	8.4%	—	76.8%	87.5%	5.4%	$942M	17.6%	46.7%	7.5%	−$3.7B	−6.3x	—	7.8%	8	$0.0M	$0.0M
Intuitive SurgicalISRG	Health Care Equipment	$159.0B	$452.29	1.9%	$10.1B	20.5%	29.3%	54.8x	18.2%	66.0%	28.4%	$2.5B	24.8%	20.9%	16.7%	−$5.9B	−1.7x	$2.3B	0.2%	5	$0.0M	$4.8M
Vertex PharmaceuticalsVRTX	Biotechnology	$133.7B	$523.93	2.1%	$12.0B	8.9%	34.8%	30.5x	14.1%	86.2%	32.9%	$3.2B	26.6%	31.5%	22.5%	−$6.5B	−1.5x	$2.0B	0.0%	6	$0.0M	$0.0M
Elevance HealthELV	Managed Health Care	$95.7B	$439.95	1.2%	$199.1B	12.5%	3.6%	18.7x	10.3%	—	2.8%	$3.2B	1.6%	15.2%	13.3%	−$3.3B	−0.4x	$4.1B	−3.6%	6	$0.0M	$0.0M
Regeneron PharmaceuticalsREGN	Biotechnology	$85.3B	$805.02	1.7%	$14.3B	1.0%	25.0%	19.9x	11.0%	—	31.4%	$4.1B	28.5%	12.7%	14.9%	−$5.9B	−1.4x	$3.8B	−5.7%	5	$0.0M	$6.5M
ModernaMRNA	Biotechnology	$79.6B	$200.10	1.2%	$1.9B	−39.9%	−158.1%	—	19.3%	55.4%	−145.2%	−$2.1B	−106.2%	−65.4%	−28.9%	−$5.2B	—	$2.0M	1.3%	2	$0.0M	$62.6M
Natera, Inc.NTRA	Services-Medical Laboratories	$57.9B	$403.95	0.6%	$2.3B	35.9%	−13.4%	—	42.6%	—	−9.0%	$109M	4.7%	−34.2%	−14.3%	−$996M	—	—	9.6%	4	$0.0M	$0.0M
Veeva SystemsVEEV	Health Care Technology	$53.3B	$323.04	0.2%	$3.2B	16.3%	28.7%	52.9x	16.9%	75.5%	28.4%	$1.4B	43.4%	—	13.9%	−$6.6B	−6.9x	$170M	1.1%	6	$0.0M	$15.2M
Edwards LifesciencesEW	Health Care Equipment	$51.4B	$89.07	1.1%	$6.1B	11.6%	20.8%	51.2x	6.7%	78.0%	17.7%	$1.3B	22.0%	15.7%	10.6%	−$3.6B	−2.6x	$893M	−2.3%	5	$0.0M	$4.5M
HumanaHUM	Managed Health Care	$50.9B	$422.07	0.3%	$129.7B	10.1%	2.1%	45.0x	10.9%	—	0.9%	$375M	0.3%	25.7%	7.0%	−$7.5B	−2.2x	$581M	−0.0%	5	$0.0M	$0.0M
ResMed \|RMD	Health Care Equipment	$36.9B	$252.86	0.1%	$5.7B	9.9%	33.4%	—	12.1%	61.1%	26.9%	$1.6B	29.2%	26.7%	24.3%	−$810M	−0.4x	$1.0B	−0.9%	6	$0.0M	$5.3M
CenteneCNC	Managed Health Care	$34.9B	$70.17	1.5%	$194.8B	19.4%	−3.9%	—	11.9%	—	−3.4%	$4.3B	2.2%	−26.4%	−28.8%	−$2.8B	—	$475M	−5.9%	5	$0.0M	$6.9M
DexcomDXCM	Health Care Equipment	$30.4B	$77.94	0.5%	$4.7B	15.6%	19.6%	30.9x	19.3%	60.1%	17.9%	$1.1B	23.1%	44.9%	34.5%	−$696M	−0.6x	$500M	−1.7%	8	$0.0M	$4.7M
West Pharmaceutical ServicesWST	Health Care Supplies	$28.0B	$392.15	0.5%	$3.1B	6.3%	19.0%	50.2x	7.4%	35.9%	16.1%	$469M	15.3%	18.7%	16.9%	−$583M	−0.8x	$195M	−1.4%	9	$0.0M	$5.4M
Zai Lab LtdZLAB	Pharmaceutical Preparations	$26.8B	$24.03	9.0%	$460M	15.3%	−49.9%	—	56.5%	58.6%	−38.1%	−$159M	−34.5%	−78.6%	−22.6%	−$485M	—	—	10.7%	3	$0.0M	$0.0M
Roivant SciencesROIV	Biotechnology	$26.3B	$36.49	2.6%	$8.3M	−71.6%	−6,235.7%	—	−19.0%	—	−3,629.2%	−$759M	−9,183.5%	−62.6%	−6.5%	−$4.3B	—	$0.0M	−4.4%	1	$0.0M	$58.9M
IncyteINCY	Biotechnology	$23.9B	$115.71	1.0%	$5.1B	21.2%	29.5%	16.3x	14.0%	92.8%	25.0%	$1.4B	26.4%	79.4%	29.9%	−$3.5B	−2.2x	$0.0M	−4.7%	8	$0.0M	$15.0M
INSMED IncINSM	Pharmaceutical Preparations	$20.3B	$93.39	1.8%	$606M	66.7%	−205.6%	—	29.8%	79.7%	−210.5%	−$968M	−159.6%	—	−249.3%	−$859M	—	—	21.3%	4	$0.0M	$0.0M
MedpaceMEDP	Life Sciences Tools & Services	$19.0B	$669.20	2.3%	$2.5B	20.0%	21.1%	37.2x	22.3%	—	17.8%	$682M	27.0%	—	70.2%	−$497M	−0.9x	$917M	−7.8%	4	$0.0M	$178M
ExelixisEXEL	Biotechnology	$16.8B	$64.53	1.2%	$2.3B	7.0%	37.6%	20.3x	18.6%	96.4%	33.7%	$876M	37.8%	64.9%	35.5%	−$1.1B	−1.2x	$948M	−4.8%	6	$0.0M	$0.5M
Neurocrine BiosciencesNBIX	Biotechnology	$14.9B	$142.70	0.4%	$2.9B	21.5%	21.6%	20.9x	22.3%	98.2%	16.7%	$749M	26.2%	25.6%	16.4%	−$1.5B	−2.3x	$168M	−1.2%	6	$0.0M	$1.1M
PenumbraPEN	Health Care Equipment	$12.8B	$324.39	0.2%	$1.4B	17.5%	13.5%	79.7x	20.2%	67.1%	12.7%	$175M	12.5%	18.8%	13.8%	−$522M	−2.5x	$0.0M	0.1%	7	$0.0M	$0.0M
Madrigal Pharmaceuticals, Inc.MDGL	Pharmaceutical Preparations	$12.7B	$434.24	4.2%	$958M	432.1%	−31.3%	—	—	—	−30.1%	−$190M	−19.8%	—	−42.5%	−$644M	—	—	5.6%	3	$0.0M	$0.0M
Bio-TechneTECH	Life Sciences Tools & Services	$11.4B	$72.55	0.1%	$1.2B	−0.4%	20.7%	—	5.5%	65.8%	15.0%	$263M	21.7%	9.2%	9.0%	−$64.7M	−0.2x	$91.6M	−1.7%	9	$0.0M	$0.0M
Globus MedicalGMED	Health Care Equipment	$11.2B	$81.41	0.3%	$2.9B	16.7%	16.3%	20.9x	30.1%	67.4%	18.3%	$589M	20.0%	11.0%	12.3%	−$556M	−0.7x	$301M	−0.6%	9	$0.0M	$4.4M
Align TechnologyALGN	Health Care Supplies	$11.0B	$154.51	0.6%	$4.0B	0.9%	13.5%	26.9x	10.3%	67.2%	10.2%	$491M	12.2%	13.3%	10.4%	−$1.1B	−1.4x	$466M	−3.2%	5	$0.0M	$0.0M
BioMarin PharmaceuticalBMRN	Biotechnology	$10.9B	$55.95	1.2%	$3.2B	12.9%	12.7%	151.2x	11.6%	77.7%	10.8%	$725M	22.5%	5.8%	5.9%	−$963M	−2.0x	$0.0M	0.4%	5	$0.0M	$1.2M
Molina HealthcareMOH	Managed Health Care	$10.8B	$209.15	3.5%	$45.4B	11.8%	1.7%	—	18.5%	—	1.0%	−$636M	−1.4%	—	11.0%	−$4.3B	−4.4x	$1.0B	−8.3%	4	$0.0M	$0.0M
Ensign GroupENSG	Health Care Facilities	$10.4B	$175.59	1.5%	$5.1B	18.7%	8.4%	27.5x	16.1%	20.5%	6.8%	—	—	19.7%	16.9%	−$428M	−0.8x	$34.4M	1.1%	6	$0.0M	$0.1M
Oscar HealthOSCR	Managed Health Care	$10.3B	$30.99	7.0%	$11.7B	27.5%	−3.4%	23.8x	90.8%	—	−3.8%	$1.1B	9.1%	—	−44.5%	−$3.6B	—	$0.0M	−1.3%	4	$0.0M	$26.8M
Corcept TherapeuticsCORT	Pharmaceuticals	$10.2B	$85.86	20.1%	$761M	12.8%	5.9%	—	16.6%	98.3%	13.1%	$142M	18.6%	15.7%	15.0%	−$372M	−8.1x	$173M	5.7%	3	$0.0M	$48.9M
Bio-Rad LaboratoriesBIO	Life Sciences Tools & Services	$9.9B	$369.95	1.8%	$2.6B	0.7%	1.8%	46.3x	0.3%	51.9%	29.4%	$375M	14.5%	0.5%	10.8%	−$329M	−1.6x	$296M	−3.3%	5	$0.0M	$0.0M
Krystal BiotechKRYS	Biotechnology	$9.6B	$311.50	2.7%	$389M	33.9%	41.5%	39.0x	—	—	52.6%	$189M	48.6%	43.6%	18.9%	−$828M	−5.0x	$0.0M	0.7%	5	$0.0M	$26.2M
Caris Life Sciences, Inc.CAI	Services-Medical Laboratories	$9.1B	$32.00	0.9%	$812M	97.0%	5.6%	3.8x	—	—	−8.4%	$66.9M	8.2%	22.7%	—	−$420M	−6.2x	$0.1M	371.0%	5	$0.0M	$0.0M
ImmunityBio, Inc.IBRX	Biological Products, (No Diagnostic Substances)	$8.6B	$8.22	1.1%	$113M	668.3%	−226.0%	—	184.8%	99.3%	−310.2%	−$309M	−272.6%	—	—	−$241M	—	—	31.3%	4	$0.0M	$0.0M
Arrowhead PharmaceuticalsARWR	Biotechnology	$8.3B	$58.02	0.6%	$829M	23,258.2%	11.9%	—	56.6%	—	−0.2%	$157M	18.9%	—	−0.5%	−$665M	−5.5x	$0.0M	11.7%	5	$0.0M	$1.2M
Axsome Therapeutics, Inc.AXSM	Pharmaceutical Preparations	$7.5B	$145.04	7.1%	$638M	65.5%	−26.1%	—	—	—	−28.7%	−$93.9M	−14.7%	—	−252.1%	−$128M	—	—	3.8%	4	$0.0M	$0.0M
Ionis Pharmaceuticals IncIONS	Pharmaceutical Preparations	$7.1B	$42.93	2.2%	$944M	33.8%	−40.4%	—	5.3%	98.3%	−40.4%	−$320M	−33.9%	—	−70.8%	−$865M	—	—	7.0%	3	$0.0M	$0.0M
ChemedCHE	Health Care Services	$6.8B	$512.98	1.4%	$2.5B	4.1%	13.4%	25.8x	4.0%	32.5%	10.5%	$325M	12.9%	27.3%	25.3%	−$74.5M	−0.2x	$463M	−4.8%	5	$0.0M	$4.8M
Ligand PharmaceuticalsLGND	Biotechnology	$6.6B	$303.53	1.4%	$268M	60.4%	15.3%	32.3x	10.4%	—	46.4%	$48.9M	18.2%	4.9%	13.5%	−$287M	−3.8x	$15.0M	11.0%	5	$0.0M	$14.6M
DoximityDOCS	Health Care Technology	$6.4B	$33.39	0.9%	$645M	13.1%	33.3%	39.3x	25.5%	89.1%	30.4%	$326M	50.6%	91.3%	19.3%	−$749M	−3.3x	$432M	−1.1%	4	$0.0M	$0.6M
Rhythm Pharmaceuticals, Inc.RYTM	Pharmaceutical Preparations	$6.1B	$89.27	1.8%	$190M	45.8%	−101.2%	—	—	89.7%	−103.6%	−$117M	−61.5%	—	−244.5%	−$281M	—	—	6.5%	6	$0.0M	$0.0M
BillionToOne, Inc.BLLN	Services-Medical Laboratories	$5.9B	$107.77	2.0%	$305M	100.0%	5.3%	103.6x	—	68.3%	2.4%	$15.7M	5.2%	37.2%	6.5%	−$438M	−19.1x	$0.0M	110.6%	7	$0.0M	$0.0M
Ptc Therapeutics, Inc.PTCT	Pharmaceutical Preparations	$5.6B	$60.59	3.9%	$1.7B	114.5%	50.1%	—	35.4%	—	39.4%	$702M	40.6%	—	—	−$1.7B	−1.8x	—	14.9%	6	$0.0M	$0.0M
CG Oncology, Inc.CGON	Biological Products, (No Diagnostic Substances)	$5.4B	$61.71	1.3%	$4.0M	254.7%	−4,722.1%	—	—	—	−3,985.0%	−$132M	−3,279.2%	−1,120.8%	−21.7%	−$739M	—	—	23.7%	2	$0.0M	$0.0M
Scholar Rock Holding CorpSRRK	Biological Products, (No Diagnostic Substances)	$5.4B	$41.49	1.1%	$0.0M	—	—	—	—	—	—	−$301M	—	—	−123.1%	−$268M	—	—	14.9%	1	$0.0M	$0.0M
Cogent Biosciences, Inc.COGT	Pharmaceutical Preparations	$5.3B	$31.21	0.3%	—	—	—	—	—	—	—	−$266M	—	—	−73.7%	−$678M	—	—	24.1%	3	$0.0M	$0.0M
CRISPR Therapeutics AGCRSP	Biological Products, (No Diagnostic Substances)	$4.8B	$49.39	1.2%	$3.5M	−90.6%	−18,933.6%	—	37.3%	—	−16,569.8%	−$346M	−9,855.5%	—	−30.2%	−$2.0B	—	—	6.6%	1	$0.0M	$0.0M
LivaNovaLIVN	Health Care Equipment	$4.6B	$80.90	0.5%	$1.4B	10.7%	14.4%	23.9x	8.2%	67.7%	−17.5%	$173M	12.5%	12.8%	−19.2%	−$260M	—	$0.0M	−0.1%	5	$0.0M	$0.8M
Arcutis Biotherapeutics, Inc.ARQT	Pharmaceutical Preparations	$4.2B	$31.20	3.1%	$376M	91.3%	−3.3%	141.8x	—	90.2%	−4.3%	−$6.3M	−1.7%	−12.5%	−9.3%	−$112M	—	—	5.2%	4	$0.0M	$0.0M

What do these columns mean?

Market cap: Last close times the latest diluted share count, so it is approximate.
Price: Closing share price on the last trading day.
Day change: Change in the closing price against the previous trading day's close.
Revenue: Total sales reported in the income statement.
Revenue growth: Change in revenue against the year (or quarter) a year earlier.
Operating margin: Operating income as a share of revenue.
P/E: Last close divided by diluted earnings per share over the last four quarters.
5-yr growth: Revenue growth a year, compounded over the last five years.
Gross margin: Gross profit as a share of revenue.
Net margin: Net income as a share of revenue.
Free cash flow: Cash from operations minus capital spending.
FCF margin: Free cash flow as a share of revenue.
Return on capital: After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Return on equity: Net income as a share of average shareholders' equity.
Net debt: Debt and finance leases minus cash and short-term investments. Negative means net cash.
Net debt / EBITDA: Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Dividends + buybacks: Cash returned to shareholders through dividends and share repurchases.
Share count change: Change in the diluted share count. Negative means buybacks shrank it.
F-score: Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
Industry: The industry the company reports under, from its SEC filing code. Click it to see its peers.
Colours and dashes: Green is up or growing, red is down or shrinking. — means no data, or a P/E that is not meaningful (losses, or above 200).
Units: M = millions, B = billions, T = trillions, in USD. Fundamentals use the latest fiscal year. Use “Edit columns” to show more figures, hide some or change their order.